284 related articles for article (PubMed ID: 3123513)
1. Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly.
Natori S; Iguchi H; Nawata H; Kato K; Ibayashi H; Nakagaki H; Chrétien M
J Clin Endocrinol Metab; 1988 Feb; 66(2):430-7. PubMed ID: 3123513
[TBL] [Abstract][Full Text] [Related]
2. Thyrotropin releasing hormone (TRH)-induced release of 7B2 (neuroendocrine polypeptide) in vivo and in vitro using adenoma cells of a patient with acromegaly.
Natori S; Iguchi H; Ohashi M; Kitamoto T; Chrétien M; Nawata H
Jpn J Med; 1991; 30(3):208-12. PubMed ID: 1920959
[TBL] [Abstract][Full Text] [Related]
3. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
4. Effect of LHRH on plasma 7B2 in patients with gonadotropin-producing pituitary adenomas.
Iguchi H; Demura R; Yasuda D; Wakasugi H
Horm Metab Res; 1992 Jan; 24(1):31-3. PubMed ID: 1612556
[TBL] [Abstract][Full Text] [Related]
5. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
[TBL] [Abstract][Full Text] [Related]
6. Effect of octapeptide somatostatin analogue (SMS 201-995) on plasma 7B2 (a neuroendocrine polypeptide) levels in patients with acromegaly.
Natori S; Iguchi H; Ohashi M; Nakao R; Bloom SR; Nawata H
Clin Endocrinol (Oxf); 1990 Jan; 32(1):49-55. PubMed ID: 2331811
[TBL] [Abstract][Full Text] [Related]
7. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
[TBL] [Abstract][Full Text] [Related]
8. LHRH increases plasma 7B2 concentration in normal human subjects.
Natori S; Iguchi H; Ohashi M; Chrétien M; Nawata H
Endocrinol Jpn; 1989 Jun; 36(3):367-71. PubMed ID: 2555142
[TBL] [Abstract][Full Text] [Related]
9. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
Matsukura S; Kakita T; Hirata Y; Yoshimi H; Fukase M
J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256
[TBL] [Abstract][Full Text] [Related]
10. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
[TBL] [Abstract][Full Text] [Related]
11. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
[TBL] [Abstract][Full Text] [Related]
12. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
[TBL] [Abstract][Full Text] [Related]
13. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
Chang CC; Chen FW; Hsieh HC
Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
[TBL] [Abstract][Full Text] [Related]
14. Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.
Utsumi A; Hanew K; Sugawara A; Shimizu Y; Murakami O; Ikeda H; Yoshinaga K
J Endocrinol Invest; 1992 Mar; 15(3):167-71. PubMed ID: 1624675
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.
Hofland LJ; van Koetsveld PM; van Vroonhoven CC; Stefanko SZ; Lamberts SW
J Clin Endocrinol Metab; 1989 Mar; 68(3):613-20. PubMed ID: 2493040
[TBL] [Abstract][Full Text] [Related]
16. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.
Colao A; Merola B; Ferone D; Calabrese MR; Longobardi S; Spaziante R; Di Renzo G; Annunziato L; Lombardi G
Eur J Endocrinol; 1994 Jul; 131(1):14-9. PubMed ID: 8038903
[TBL] [Abstract][Full Text] [Related]
17. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
[TBL] [Abstract][Full Text] [Related]
18. Secretory mechanisms of growth hormone (GH)-releasing peptide-, GH-releasing hormone-, and thyrotropin-releasing hormone-induced GH release in patients with acromegaly.
Hanew K; Utsumi A; Tanaka A; Ikeda H; Yokogoshi Y
J Clin Endocrinol Metab; 1998 Oct; 83(10):3578-83. PubMed ID: 9768668
[TBL] [Abstract][Full Text] [Related]
19. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly.
Watanobe H; Tamura T
Neuropeptides; 1995 Feb; 28(2):115-24. PubMed ID: 7746355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
